DRISCOLL FREDERICK W — SEC insider filings

SEC reporting owner CIK 1129890. 23 insider filings on record with FilingPulse; latest filed 2026-10-26.

Transaction summary — filings shown

Covers all 23 filings on record, filed 2020-08-13 to 2026-10-26. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
NantKwest, Inc. (NK)Director1—3 legs · 65,300 sh · $668,052—
Lite Strategy, Inc. (LITS)Director7—1 leg · 25,000 sh · $100,6256
Cellectar Biosciences, Inc. (CLRB)Director71 leg · 19,417 sh · $20,244—6
Cue Biopharma, Inc. (CUE)Director5——5
Flexion Therapeutics Inc (FLXN)Chief Financial Officer2——4
Renovacor, Inc. (RCOR)Chief Financial Officer1——1

Insider filings — DRISCOLL FREDERICK W

FiledFormIssuerReported transactionsSource
2026-10-264Lite Strategy, Inc. (LITS)Grant/award (A): 100,000 (derivative) @ $0EDGAR
2026-07-084Cellectar Biosciences, Inc. (CLRB)Grant/award (A): 25,000 (derivative) @ $0EDGAR
2025-11-184Lite Strategy, Inc. (LITS)Grant/award (A): 55,000 (derivative)EDGAR
2025-07-174MEI Pharma, Inc. (MEIP)Grant/award (A): 20,000 (derivative) @ $0EDGAR
2025-02-184Cellectar Biosciences, Inc. (CLRB)Grant/award (A): 60,000 (derivative) @ $0EDGAR
2025-01-034Cue Biopharma, Inc. (CUE)Grant/award (A): 24,400 (derivative) @ $0EDGAR
2024-06-184Cellectar Biosciences, Inc. (CLRB)Grant/award (A): 60,000 (derivative) @ $0EDGAR
2024-01-044Cue Biopharma, Inc. (CUE)Grant/award (A): 24,400 (derivative) @ $0EDGAR
2023-10-124MEI Pharma, Inc. (MEIP)Grant/award (A): 10,000 (derivative) @ $0EDGAR
2023-06-284Cellectar Biosciences, Inc. (CLRB)Grant/award (A): 25,000 (derivative) @ $0EDGAR
2023-01-054Cue Biopharma, Inc. (CUE)Grant/award (A): 10,000 (derivative) @ $0EDGAR
2022-08-014Cellectar Biosciences, Inc. (CLRB)Grant/award (A): 7,800 (derivative) @ $0EDGAR
2022-07-074MEI Pharma, Inc. (MEIP)Grant/award (A): 87.50 (derivative) @ $0EDGAR
2022-03-284Renovacor, Inc. (RCOR)Grant/award (A): 155,325 (derivative) @ $0EDGAR
2022-01-054Cue Biopharma, Inc. (CUE)Grant/award (A): 10,000 (derivative) @ $0EDGAR
2021-11-194Flexion Therapeutics Inc (FLXN)Disposition to issuer (D): 30,680 @ $8.50 · Disposition to issuer (D): 168,000 (derivative)EDGAR
2021-09-074Cellectar Biosciences, Inc. (CLRB)Purchase (P): 19,417 @ $1.04EDGAR
2021-07-064MEI Pharma, Inc. (MEIP)Grant/award (A): 50,000 (derivative) @ $0EDGAR
2021-07-024Cellectar Biosciences, Inc. (CLRB)Grant/award (A): 78,000 (derivative) @ $0EDGAR
2021-06-034Flexion Therapeutics Inc (FLXN)Grant/award (A): 28,000 @ $0 · Grant/award (A): 168,000 (derivative) @ $0EDGAR
2021-02-244MEI Pharma, Inc. (MEIP)Sale (S): 25,000 @ $4.03EDGAR
2021-01-064Cue Biopharma, Inc. (CUE)Grant/award (A): 10,000 (derivative) @ $0EDGAR
2020-08-134NantKwest, Inc. (NK)Sale (S): 50,000 @ $10.22 · Sale (S): 10,000 @ $9.98 · Sale (S): 5,300 @ $10.77EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-08-10 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1129890 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs